These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16556859)

  • 1. Oxidized LDL and the metabolic syndrome.
    Holvoet P; Harris TB; Tracy RP; Kritchevsky SB
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):e31; author reply e31-2. PubMed ID: 16556859
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome.
    Park SH; Kim JY; Lee JH; Park HY
    Clin Chim Acta; 2011 Feb; 412(5-6):435-40. PubMed ID: 21093421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal measurement invariance of the metabolic syndrome: is the assessment of the metabolic syndrome stable over time?
    Barbosa-Leiker C; Wright BR; Burns GL; Parks CD; Strand PS
    Ann Epidemiol; 2011 Feb; 21(2):111-7. PubMed ID: 21109452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
    Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT
    Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome.
    Pettersson C; Karlsson H; Ståhlman M; Larsson T; Fagerberg B; Lindahl M; Wiklund O; Borén J; Fogelstrand L
    J Intern Med; 2011 Mar; 269(3):306-21. PubMed ID: 21205019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models.
    Pohjantähti-Maaroos H; Palomäki A; Kankkunen P; Husgafvel S; Knuth T; Vesterinen K; Oksanen K
    Ann Med; 2012 Aug; 44(5):503-12. PubMed ID: 21726125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese.
    Ueba T; Nomura S; Nishikawa T; Kajiwara M; Yamashita K
    Atherosclerosis; 2009 Mar; 203(1):243-8. PubMed ID: 18635189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL heterogeneity revisited: lesson for the metabolic syndrome from a new interpopulation study?
    Chan DC; Watts GF
    Eur J Clin Invest; 2004 Nov; 34(11):719-22. PubMed ID: 15530143
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus.
    El Magadmi M; Ahmad Y; Turkie W; Yates AP; Sheikh N; Bernstein RM; Durrington PN; Laing I; Bruce IN
    J Rheumatol; 2006 Jan; 33(1):50-6. PubMed ID: 16395749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of iron status and oxidative stress in patients with metabolic syndrome.
    Leiva E; Mujica V; Sepúlveda P; Guzmán L; Núñez S; Orrego R; Palomo I; Andrews M; Arredondo MA
    Biol Trace Elem Res; 2013 Jan; 151(1):1-8. PubMed ID: 23079936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome.
    Yeo HY; Kim OY; Lim HH; Kim JY; Lee JH
    Metabolism; 2011 Apr; 60(4):537-43. PubMed ID: 20580031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.
    Gazi I; Tsimihodimos V; Filippatos T; Bairaktari E; Tselepis AD; Elisaf M
    Metabolism; 2006 Jul; 55(7):885-91. PubMed ID: 16784959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations on cardiovascular risk factors in metabolic syndrome after consume of a citrus-based juice.
    Mulero J; Bernabé J; Cerdá B; García-Viguera C; Moreno DA; Albaladejo MD; Avilés F; Parra S; Abellán J; Zafrilla P
    Clin Nutr; 2012 Jun; 31(3):372-7. PubMed ID: 22197455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid metabolism in patients with type 2 diabetes mellitus with and without the metabolic syndrome].
    Kulieva NF
    Georgian Med News; 2009 Jan; (166):58-60. PubMed ID: 19202221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y
    Hypertens Res; 2009 Nov; 32(11):1004-8. PubMed ID: 19763135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects.
    Schwab U; Alfthan G; Aro A; Uusitupa M
    Eur J Clin Nutr; 2011 Jan; 65(1):70-6. PubMed ID: 20978525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
    Kathiresan S; Otvos JD; Sullivan LM; Keyes MJ; Schaefer EJ; Wilson PW; D'Agostino RB; Vasan RS; Robins SJ
    Circulation; 2006 Jan; 113(1):20-9. PubMed ID: 16380547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.